ScholarIQanswers from OpenAlex

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma

PaperCitations, authors & open-access status

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma have?

ScholarIQcitation count

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma has 392 citations in the OpenAlex counts ScholarIQ stores.

When was ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma published?

ScholarIQyear

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma has 2015 year in the ScholarIQ index.

What is the open-access status of ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma?

ScholarIQoa status

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma has bronze oa status in the ScholarIQ index.

What is the DOI of ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma?

ScholarIQdoi

The DOI for ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma is on the source record.

What is the PMID of ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma?

ScholarIQpmid

The PMID for ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma is on the source record.

What is the OpenAlex record for ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma?

ScholarIQopenalex

The OpenAlex for ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial